Matches in Wikidata for { <http://www.wikidata.org/entity/Q83209550> ?p ?o ?g. }
- Q83209550 description "2009 nî lūn-bûn" @default.
- Q83209550 description "2009年の論文" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年学术文章" @default.
- Q83209550 description "2009年學術文章" @default.
- Q83209550 description "2009年學術文章" @default.
- Q83209550 description "2009年學術文章" @default.
- Q83209550 description "2009年學術文章" @default.
- Q83209550 description "2009年學術文章" @default.
- Q83209550 description "2009년 논문" @default.
- Q83209550 description "article científic" @default.
- Q83209550 description "article scientific" @default.
- Q83209550 description "article scientifique" @default.
- Q83209550 description "articol științific" @default.
- Q83209550 description "articolo scientifico" @default.
- Q83209550 description "artigo científico" @default.
- Q83209550 description "artigo científico" @default.
- Q83209550 description "artigo científico" @default.
- Q83209550 description "artikel ilmiah" @default.
- Q83209550 description "artikull shkencor" @default.
- Q83209550 description "artikulong pang-agham" @default.
- Q83209550 description "artykuł naukowy" @default.
- Q83209550 description "artículo científico publicado en 2009" @default.
- Q83209550 description "artículu científicu" @default.
- Q83209550 description "bilimsel makale" @default.
- Q83209550 description "bài báo khoa học" @default.
- Q83209550 description "naučni članak" @default.
- Q83209550 description "scienca artikolo" @default.
- Q83209550 description "scientific article published on 21 January 2009" @default.
- Q83209550 description "scientific article published on 21 January 2009" @default.
- Q83209550 description "scientific article published on 21 January 2009" @default.
- Q83209550 description "teaduslik artikkel" @default.
- Q83209550 description "tieteellinen artikkeli" @default.
- Q83209550 description "tudományos cikk" @default.
- Q83209550 description "vedecký článok" @default.
- Q83209550 description "vetenskaplig artikel" @default.
- Q83209550 description "videnskabelig artikel udgivet 21. januar 2009" @default.
- Q83209550 description "vitenskapelig artikkel" @default.
- Q83209550 description "vitskapeleg artikkel" @default.
- Q83209550 description "vědecký článek" @default.
- Q83209550 description "wetenschappelijk artikel" @default.
- Q83209550 description "wissenschaftlicher Artikel" @default.
- Q83209550 description "επιστημονικό άρθρο" @default.
- Q83209550 description "мақолаи илмӣ" @default.
- Q83209550 description "наукова стаття, опублікована в січні 2009" @default.
- Q83209550 description "научна статия" @default.
- Q83209550 description "научная статья" @default.
- Q83209550 description "научни чланак" @default.
- Q83209550 description "научни чланак" @default.
- Q83209550 description "מאמר מדעי" @default.
- Q83209550 description "مقالة علمية نشرت في 21 يناير 2009" @default.
- Q83209550 description "২১ জানুয়ারি ২০০৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q83209550 description "บทความทางวิทยาศาสตร์" @default.
- Q83209550 description "სამეცნიერო სტატია" @default.
- Q83209550 name "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 name "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 type Item @default.
- Q83209550 label "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 label "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 prefLabel "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 prefLabel "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 P1433 Q83209550-1B68232B-EF57-4DE5-8C18-40ABAAB302C8 @default.
- Q83209550 P1476 Q83209550-F752C493-BDF6-41D2-B134-702880AEAD10 @default.
- Q83209550 P2093 Q83209550-2B44CEF5-93E9-471F-9BC6-B328E7188D49 @default.
- Q83209550 P2093 Q83209550-4068B5C8-FF51-4771-A975-2C60ED463A5A @default.
- Q83209550 P2093 Q83209550-B4084E30-E611-4B2A-BE38-E7075DAC0A17 @default.
- Q83209550 P2093 Q83209550-BB4C07B7-9DFF-4A94-A609-CA4618F38B40 @default.
- Q83209550 P2093 Q83209550-EC734E37-4CAC-49BC-A4F1-F7C1BAF5D2B2 @default.
- Q83209550 P2093 Q83209550-F77400B8-A21F-405B-8909-1DFFD78289DF @default.
- Q83209550 P2888 Q83209550-35DC2D17-74AA-436A-AE22-5C7B3D851EB6 @default.
- Q83209550 P304 Q83209550-CA5B6668-F507-479B-BA56-9B59E63681D6 @default.
- Q83209550 P31 Q83209550-51068A8B-3CC8-4BD7-89A6-268A9D8D95F3 @default.
- Q83209550 P356 Q83209550-FBE07DD2-5C0A-46F4-9E05-BBC6D892A0C2 @default.
- Q83209550 P433 Q83209550-0FB19469-507E-498F-AD24-A872382DC6C8 @default.
- Q83209550 P478 Q83209550-D8912AA5-C3AF-4D39-BE6E-FA79E8A51381 @default.
- Q83209550 P50 Q83209550-F543B5C2-CB84-4E96-8946-0FF315A09D59 @default.
- Q83209550 P577 Q83209550-F4B2AD4B-3FCF-4663-BE68-AAC030B671CA @default.
- Q83209550 P6179 Q83209550-CCD787E7-2FE6-427E-8F06-D8D1A7A068FE @default.
- Q83209550 P698 Q83209550-2633D84B-EA38-4B95-9FFE-A8F8DCB236BF @default.
- Q83209550 P921 Q83209550-0D31477C-568E-486C-AF77-ED0E50FF1FC4 @default.
- Q83209550 P921 Q83209550-0DEF1581-1F18-451D-A834-81B9432527AA @default.
- Q83209550 P921 Q83209550-33DBA473-FAE8-431B-9496-C2C672B2C07F @default.
- Q83209550 P921 Q83209550-93B1B707-B855-4EFA-BEA4-6E2F88418164 @default.
- Q83209550 P921 Q83209550-F39317E0-261E-4331-B995-23735846EE62 @default.
- Q83209550 P356 S10549-008-0306-9 @default.
- Q83209550 P698 19156515 @default.
- Q83209550 P1433 Q326085 @default.
- Q83209550 P1476 "Pegylated liposomal doxorubicin and trastuzumab as 1st and 2nd line therapy in her2/neu positive metastatic breast cancer: a multicenter phase II trial" @default.
- Q83209550 P2093 "Annette Geibel" @default.
- Q83209550 P2093 "Annette Hasenburg" @default.
- Q83209550 P2093 "Dirk Watermann" @default.
- Q83209550 P2093 "Elmar Stickeler" @default.
- Q83209550 P2093 "Gerald Gitsch" @default.
- Q83209550 P2093 "Martha Földi" @default.
- Q83209550 P2888 s10549-008-0306-9 @default.
- Q83209550 P304 "591-598" @default.